HIGHLIGHTS
- ABIONYX has signed a strategic partnership with GTP biologics and V-Nano.
- The key purpose of this partnership is the Bioproduction of the bio-HDL CER-001 in France.
- Bioengineering redevelopment for the production of bio-HDL and CER-001 is on cards.
- There are plans regarding relocation of the bioproduction to France.
A new generation biotech company....
Tags : ABIONYX Pharma, GTP biologics, V-Nano, bioproduction, biological nanomedicines, CER-001,
comments (0)